<Important Notes>
The forward-looking statements contained in this presentation are based on the Company’s assumptions and beliefs in the light of information currently available to it and involves known and unknown risks and uncertainties. Accordingly, there is a possibility that actual results and development programs may differ largely from these forecasts, due to a variety of factors. This report contains information on 바카라 먹튀 검증 products (including those under development), and the content of this report is not intended for medical promotion or medical advice. This translation is provided solely as a reference material. In the case of any discrepancy between the two versions, the original Japanese version shall prevail.
- 2024 년 3 월 26 일바카라 먹튀 검증 Pharmaceutical Receives Approval for Partial Change of Manufacturing and Marketing Approval for RIFXIMA® TABLETS for Pediatric Indication
- 2024 년 3 월 21 일Newsweek International Features 바카라 먹튀 검증 Pharmaceutical
- 2024 년 3 월 18 일Red Arrow Therapeutics and 바카라 먹튀 검증 Pharmaceutical Sign Joint Research Agreement on Novel Preeclampsia Treatment
- 2024 년 2 월 224Organizational and Personnel Changes of 바카라 먹튀 검증 Pharmaceutical
- 2024 년 1 월 18 일바카라 먹튀 검증 Pharmaceutical Invests in NEXTBLUE Fund 2, a Fund Specializing in the Realm of Women's Wellbeing
- 2024 년 1 월 15 일바카라 먹튀 검증 Pharmaceutical Executes Capital Increase to Ha Tay Pharmaceutical Joint Stock Company
- 2023 년 11 월 13 일바카라 먹튀 검증 Pharmaceutical Featured in a Special Feature in TIME Magazine
- 2023 년 9 월 21 일바카라 먹튀 검증 Pharmaceutical Holdings Participates at 2nd Femtech Tokyo
- 2023 년 9 월 21 일바카라 먹튀 검증 Pharmaceutical Launches Training Videos on Women's Health
- 2023 년 9 월 14 일Newsweek International Features 바카라 먹튀 검증 Pharmaceutical
- 2023 년 8 월 25 일Organizational and Personnel Changes of 바카라 먹튀 검증 Pharmaceutical
- 2023 년 7 월 20 일바카라 먹튀 검증 Pharmaceutical Initiates Domestic Phase I II Clinical Trial of Relugolix Combination Tablet (AKP-022)
- 2023 년 6 월 27 일Personnel Changes of Corporate Officers and Board Members of 바카라 먹튀 검증 Pharmaceutical Holdings Subsidiaries
- 2023 년 6 월 22 일바카라 먹튀 검증 Pharmaceutical Files an Application for Partial Change of Manufacturing and Marketing Approval for RIFXIMA
- 2023 년 6 월 9 일바카라 먹튀 검증 Pharmaceutical Terminates Joint Research Agreement regarding the Drug Discovery Targeting Specific Ion Channels with RaQualia Pharma
- 2023 년 4 월 24 일바카라 먹튀 검증 Pharmaceutical Enters into a Comprehensive Business Alliance Agreement on Femtech
- 2023 년 4 월 21 일바카라 먹튀 검증 Pharmaceutical Holdings Installs CO₂-Free Electricity and Solar Power Generation Facilities
- 2023 년 4 월 7 일바카라 먹튀 검증 Pharmaceutical Terminates Option Agreement with KinoPharma regarding Cervical Dysplasia Treatment
- 2023 년 4 월 7 일바카라 먹튀 검증 licensee Hyundai files New Drug Application in Korea for OC Drospirenone
- 2023 년 4 월 3 일바카라 먹튀 검증 Pharmaceutical and Future Venture Capital Co-found a Corporate Venture Capital Fund
이전 뉴스 릴리스의 경우 바카라 먹튀 검증 Pharmaceutical Holdings Co., Ltd. 웹 사이트를 참조하십시오.